EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 317 filers reported holding EDITAS MEDICINE INC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,529 | -13.8% | 8,914 | -9.1% | 0.04% | -12.5% |
| Q2 2023 | $80,695 | +13.9% | 9,805 | +0.4% | 0.05% | +23.1% |
| Q1 2023 | $70,825 | -40.9% | 9,769 | -27.7% | 0.04% | -38.1% |
| Q4 2022 | $119,922 | -6.3% | 13,520 | +29.5% | 0.06% | +23.5% |
| Q3 2022 | $128,000 | +4.1% | 10,440 | +0.7% | 0.05% | +10.9% |
| Q2 2022 | $123,000 | +19.4% | 10,370 | +91.2% | 0.05% | 0.0% |
| Q1 2022 | $103,000 | -32.2% | 5,425 | -5.5% | 0.05% | -19.3% |
| Q4 2021 | $152,000 | -33.0% | 5,740 | +4.0% | 0.06% | -43.0% |
| Q3 2021 | $227,000 | -31.0% | 5,518 | -5.0% | 0.10% | -25.9% |
| Q2 2021 | $329,000 | +60.5% | 5,806 | +18.9% | 0.14% | +55.2% |
| Q1 2021 | $205,000 | -39.0% | 4,884 | +1.8% | 0.09% | -37.4% |
| Q4 2020 | $336,000 | +5.0% | 4,798 | -58.0% | 0.14% | -17.3% |
| Q3 2020 | $320,000 | -16.7% | 11,417 | -12.1% | 0.17% | -7.7% |
| Q2 2020 | $384,000 | – | 12,987 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
| Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
| ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
| Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
| Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
| DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
| Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
| DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
| Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |